B

서울바이오시스

092190KOSDAQ

57.8 / 100

Reference Date: 2026-09-08

Financial Score16.5 / 40
News Sentiment21.3 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 31.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Seoul Biosys provides comprehensive solutions ranging from UV to IR, laser diodes, and VCSELs through six global R&D centers and production infrastructure, with over 7,000 patents protecting its 200nm–1600nm wavelength optical semiconductor technology. The company leads in key markets such as automotive lighting and UV LED, where it holds the top market share, and is projected to grow at a 12% annual rate across six major industries including micro LED and VCSEL.

Number of Employees

193people

Average Salary

60.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 15.004.0Point
PBR
2.15Industry Average 1.201.0Point

1.8x industry avg (risky)

ROE
-8.97Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
38.40Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲24.0% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲5.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -23.7% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position3.0Point

52w lower range (37%)

Current 7,970Won52-week high 17,57052-week low 2,185
1-month return6.0Point

1m +31.74% (strong rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral연결재무제표기준영업실적등에대한전망(공정공시)2026-08-10
  • Neutral[기재정정]연결재무제표기준영업(잠정)실적(공정공시)2026-08-10